Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population
Amyloid-beta (Aβ) is a pathological hallmark of Alzheimer's disease (AD). We aimed to identify genes related to Aβ uptake in the Korean population and investigate the effects of these novel genes on clinical outcomes, including neurodegeneration and cognitive impairments. We recruited a total o...
Saved in:
Published in | Frontiers in aging neuroscience Vol. 15; p. 1278998 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
12.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Amyloid-beta (Aβ) is a pathological hallmark of Alzheimer's disease (AD). We aimed to identify genes related to Aβ uptake in the Korean population and investigate the effects of these novel genes on clinical outcomes, including neurodegeneration and cognitive impairments. We recruited a total of 759 Korean participants who underwent neuropsychological tests, brain magnetic resonance imaging,
F-flutemetamol positron emission tomography, and microarray genotyping data. We performed gene-based association analysis, and also performed expression quantitative trait loci and network analysis. In genome-wide association studies, no single nucleotide polymorphism (SNP) passed the genome-wide significance threshold. In gene-based association analysis, six genes (
,
,
,
,
, and
) were significantly associated with Aβ standardised uptake value ratio in the brain. The three most significant SNPs (rs4787307, rs9903904, and rs11079797) on these genes are associated with the regulation of the
,
, and
genes, respectively. These SNPs are involved in decreasing hippocampal volume and cognitive scores by mediating Aβ uptake. The 19 enriched gene sets identified by pathway analysis included axon and chemokine activity. Our findings suggest novel susceptibility genes associated with the uptake of Aβ, which in turn leads to worse clinical outcomes. Our findings might lead to the discovery of new AD treatment targets. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Konstantinos Xanthopoulos, Aristotle University of Thessaloniki, Greece; Stefania Zampatti, Santa Lucia Foundation (IRCCS), Italy; Mohammad Ejaz Ahmed, Henry Ford Health System, United States Edited by: Selvakumar Govindhasamy Pushpavathi, The University of Iowa, United States |
ISSN: | 1663-4365 1663-4365 |
DOI: | 10.3389/fnagi.2023.1278998 |